{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["gut microbiota", "gut mucosal environment", "gynostemma pentaphyllum", "herbal saponins", "pyrosequencing"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27121311", "DateCompleted": {"Year": "2017", "Month": "12", "Day": "25"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [], "ELocationID": ["10.18632/oncotarget.8886"], "Language": ["eng"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "7", "Issue": "21", "PubDate": {"Year": "2016", "Month": "May", "Day": "24"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice.", "Pagination": {"StartPage": "31226", "EndPage": "31242", "MedlinePgn": "31226-42"}, "Abstract": {"AbstractText": ["Saponins derived from medicinal plants have raised considerable interest for their preventive roles in various diseases. Here, we investigated the impacts of triterpenoid saponins isolated from Gynostemma pentaphyllum (GpS) on gut microbiome, mucosal environment, and the preventive effect on tumor growth. Six-week old ApcMin/+ mice and their wild-type littermates were fed either with vehicle or GpS daily for the duration of 8 weeks. The fecal microbiome was analyzed by enterobacterial repetitive intergenic consensus (ERIC)-PCR and 16S rRNA gene pyrosequencing. Study showed that GpS treatment significantly reduced the number of intestinal polyps in a preventive mode. More importantly, GpS feeding strikingly reduced the sulfate-reducing bacteria lineage, which are known to produce hydrogen sulfide and contribute to damage the intestinal epithelium or even promote cancer progression. Meanwhile, GpS also boosted the beneficial microbes. In the gut barrier of the ApcMin/+ mice, GpS treatment increased Paneth and goblet cells, up-regulated E-cadherin and down-regulated N-cadherin. In addition, GpS decreased the pro-oncogenic \u03b2-catenin, p-Src and the p-STAT3. Furthermore, GpS might also improve the inflamed gut epithelium of the ApcMin/+ mice by upregulating the anti-inflammatory cytokine IL-4, while downregulating pro-inflammatory cytokines TNF-\u03b1, IL-1\u03b2 and IL-18. Intriguingly, GpS markedly stimulated M2 and suppressed M1 macrophage markers, indicating that GpS altered mucosal cytokine profile in favor of the M1 to M2 macrophages switching, facilitating intestinal tissue repair. In conclusion, GpS might reverse the host's inflammatory phenotype by increasing beneficial bacteria, decreasing sulfate-reducing bacteria, and alleviating intestinal inflammatory gut environment, which might contribute to its cancer preventive effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Cancer & Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China."}], "LastName": "Chen", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biological Sciences, University of Hong Kong, Pokfulam, Hong Kong, China."}], "LastName": "Brar", "ForeName": "Manreetpal S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biological Sciences, University of Hong Kong, Pokfulam, Hong Kong, China."}], "LastName": "Leung", "ForeName": "Frederick C C", "Initials": "FC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, China."}], "LastName": "Hsiao", "ForeName": "W L Wendy", "Initials": "WL"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adenomatous Polyposis Coli Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Ribosomal, 16S"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfates"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "adenomatous polyposis coli protein, mouse"}], "MeshHeadingList": [{"QualifierName": ["genetics", "microbiology", "prevention & control"], "DescriptorName": "Adenomatous Polyposis Coli"}, {"QualifierName": ["deficiency", "genetics"], "DescriptorName": "Adenomatous Polyposis Coli Protein"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["classification", "drug effects", "genetics"], "DescriptorName": "Bacteria"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["microbiology"], "DescriptorName": "Feces"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["chemistry"], "DescriptorName": "Gynostemma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": ["drug effects", "microbiology"], "DescriptorName": "Intestines"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA, Ribosomal, 16S"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": ["methods"], "DescriptorName": "Sequence Analysis, DNA"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sulfates"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Triterpenes"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320\u2013329.", "ArticleIdList": ["PMC3260502", "21850056"]}, {"Citation": "Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS one. 2011;6:e16393.", "ArticleIdList": ["PMC3029306", "21297998"]}, {"Citation": "Chen HM, Yu YN, Wang JL, Lin YW, Kong X, Yang CQ, Yang L, Liu ZJ, Yuan YZ, Liu F, Wu JX, Zhong L, Fang DC, Zou W, Fang JY. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr. 2013;97:1044\u20131052.", "ArticleIdList": ["23553152"]}, {"Citation": "Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, Karre K, Pettersson S, Greicius G. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis. 2012;33:1231\u20131238.", "ArticleIdList": ["22461519"]}, {"Citation": "Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PloS one. 2009;4:e6026.", "ArticleIdList": ["PMC2696084", "19551144"]}, {"Citation": "Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN, Glimcher LH. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131:33\u201345.", "ArticleIdList": ["PMC2169385", "17923086"]}, {"Citation": "Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T, Bressenot A, Delanoye-Crespin A, Gaillot O, Schreiber S, Lemoine Y, Ryffel B, Hot D, Nunez G, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. The Journal of clinical investigation. 2013;123:700\u2013711.", "ArticleIdList": ["PMC3561825", "23281400"]}, {"Citation": "Irrazabal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. The multifaceted role of the intestinal microbiota in colon cancer. Molecular cell. 2014;54:309\u2013320.", "ArticleIdList": ["24766895"]}, {"Citation": "Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2014;308:G351\u2013363.", "ArticleIdList": ["PMC4346754", "25540232"]}, {"Citation": "Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759\u2013771.", "ArticleIdList": ["24154716"]}, {"Citation": "Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575\u2013582.", "ArticleIdList": ["22728587"]}, {"Citation": "Sears CL, Garrett WS. Microbes, Microbiota, and Colon Cancer. Cell host & microbe. 2014;15:317\u2013328.", "ArticleIdList": ["PMC4003880", "24629338"]}, {"Citation": "Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick EC, Hechenbleikner EM, Uritboonthai W, Goetz L, Casero RA, Jr, Pardoll DM, White JR, Patti GJ, et al. Metabolism Links Bacterial Biofilms and Colon Carcinogenesis. Cell Metab. 2015;21:891\u2013897.", "ArticleIdList": ["PMC4456201", "25959674"]}, {"Citation": "Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12:661\u2013672.", "ArticleIdList": ["25198138"]}, {"Citation": "Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342:971\u2013976.", "ArticleIdList": ["PMC4048947", "24264990"]}, {"Citation": "Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967\u2013970.", "ArticleIdList": ["PMC6709532", "24264989"]}, {"Citation": "Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem. 2009;20:743\u2013752.", "ArticleIdList": ["PMC2743755", "19716282"]}, {"Citation": "Macdonald RS, Wagner K. Influence of Dietary Phytochemicals and Microbiota on Colon Cancer Risk. J Agric Food Chem. 2012;60:6728\u20136735.", "ArticleIdList": ["22632581"]}, {"Citation": "Fotiadis CI, Stoidis CN, Spyropoulos BG, Zografos ED. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J Gastroenterol. 2008;14:6453\u20136457.", "ArticleIdList": ["PMC2773329", "19030195"]}, {"Citation": "Chen L, Tai CS, Hsiao WL. Dietary saponins from four popular herbal tea exert prebiotic-like effects on gut microbiota in C57BL/6 mice. J Funct Foods. 2015;17:892\u2013902."}, {"Citation": "Chen L, Tai WC, Brar MS, Leung FC, Hsiao WL. Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal gynostemma saponins. PLoS One. 2015;10:e0126807.", "ArticleIdList": ["PMC4439139", "25992551"]}, {"Citation": "Medani M, Collins D, Docherty NG, Baird AW, O'Connell PR, Winter DC. Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm Bowel Dis. 2011;17:1620\u20131625.", "ArticleIdList": ["21674719"]}, {"Citation": "Carbonero F, Benefiel AC, Gaskins HR. Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol. 2012;9:504\u2013518.", "ArticleIdList": ["22585131"]}, {"Citation": "Pereyra LP, Hiibel SR, Prieto Riquelme MV, Reardon KF, Pruden A. Detection and quantification of functional genes of cellulose-degrading, fermentative, and sulfate-reducing bacteria and methanogenic archaea. Appl Environ Microbiol. 2010;76:2192\u20132202.", "ArticleIdList": ["PMC2849247", "20139321"]}, {"Citation": "Kersters K, Vos PD, Gillis M, Swings J, Vandamme P, Stackebrandt E. Introduction to the Proteobacteria. The Prokaryotes: a handbook on the biology of bacteria. 2006:3\u201337."}, {"Citation": "Regalado NG, Martin G, Antony SJ. Acinetobacter lwoffii: bacteremia associated with acute gastroenteritis. Travel Med Infect Dis. 2009;7:316\u2013317.", "ArticleIdList": ["19747669"]}, {"Citation": "Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012;491:254\u2013258.", "ArticleIdList": ["PMC3601659", "23034650"]}, {"Citation": "Bondow BJ, Faber ML, Wojta KJ, Walker EM, Battle MA. E-cadherin is required for intestinal morphogenesis in the mouse. Developmental biology. 2012;371:1\u201312.", "ArticleIdList": ["PMC3455111", "22766025"]}, {"Citation": "Schneider MR, Dahlhoff M, Horst D, Hirschi B, Trulzsch K, Muller-Hocker J, Vogelmann R, Allgauer M, Gerhard M, Steininger S, Wolf E, Kolligs FT. A key role for E-cadherin in intestinal homeostasis and Paneth cell maturation. PloS one. 2010;5:e14325.", "ArticleIdList": ["PMC3001873", "21179475"]}, {"Citation": "Halbleib JM, Nelson WJ. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes & development. 2006;20:3199\u20133214.", "ArticleIdList": ["17158740"]}, {"Citation": "Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem. 2012;287:5819\u20135832.", "ArticleIdList": ["PMC3285352", "22205702"]}, {"Citation": "Lee H, Pal SK, Reckamp K, Figlin RA, Yu H. STAT3: a target to enhance antitumor immune response. Curr Top Microbiol Immunol. 2011;344:41\u201359.", "ArticleIdList": ["PMC3244828", "20517723"]}, {"Citation": "Cheesman SE, Neal JT, Mittge E, Seredick BM, Guillemin K. Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signaling via Myd88. Proceedings of the National Academy of Sciences of the United States of America; 2010; pp. 4570\u20134577.", "ArticleIdList": ["PMC3063593", "20921418"]}, {"Citation": "Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol. 1999;162:6233\u20136237.", "ArticleIdList": ["10229869"]}, {"Citation": "Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. Journal of leukocyte biology. 2013;93:875\u2013881.", "ArticleIdList": ["PMC3656331", "23505314"]}, {"Citation": "Luzina IG, Keegan AD, Heller NM, Rook GA, Shea-Donohue T, Atamas SP. Regulation of inflammation by interleukin-4: a review of \u201calternatives\u201d. Journal of leukocyte biology. 2012;92:753\u2013764.", "ArticleIdList": ["PMC3441310", "22782966"]}, {"Citation": "Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787\u2013795.", "ArticleIdList": ["PMC3287223", "22378047"]}, {"Citation": "McClellan JL, Davis JM, Steiner JL, Day SD, Steck SE, Carmichael MD, Murphy EA. Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse. Cytokine. 2012;57:113\u2013119.", "ArticleIdList": ["PMC3367310", "22056354"]}, {"Citation": "Abe F, Ishibashi N, Shimamura S. Effect of administration of bifidobacteria and lactic acid bacteria to newborn calves and piglets. J Dairy Sci. 1995;78:2838\u20132846.", "ArticleIdList": ["8675766"]}, {"Citation": "Guarner F, Perdigon G, Corthier G, Salminen S, Koletzko B, Morelli L. Should yoghurt cultures be considered probiotic? Br J Nutr. 2005;93:783\u2013786.", "ArticleIdList": ["16022746"]}, {"Citation": "Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J, Verdu EF, Tlaskalova-Hogenova H. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2011;163:250\u2013259.", "ArticleIdList": ["PMC3043316", "21087444"]}, {"Citation": "Boureau H, Decre D, Carlier JP, Guichet C, Bourlioux P. Identification of a Clostridium cocleatum strain involved in an anti-Clostridium difficile barrier effect and determination of its mucin-degrading enzymes. Research in microbiology. 1993;144:405\u2013410.", "ArticleIdList": ["7504316"]}, {"Citation": "Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24\u201333.", "ArticleIdList": ["17631127"]}, {"Citation": "Yanagibashi T, Hosono A, Oyama A, Tsuda M, Suzuki A, Hachimura S, Takahashi Y, Momose Y, Itoh K, Hirayama K, Takahashi K, Kaminogawa S. IgA production in the large intestine is modulated by a different mechanism than in the small intestine: Bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA(+) B cells. Immunobiology. 2012;218:645\u2013651.", "ArticleIdList": ["22940255"]}, {"Citation": "Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Frontiers in physiology. 2012;3:448.", "ArticleIdList": ["PMC3508456", "23226130"]}, {"Citation": "Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10\u2212/\u2212 mice. Nature. 2012;487:104\u2013108.", "ArticleIdList": ["PMC3393783", "22722865"]}, {"Citation": "Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome medicine. 2011;3:14.", "ArticleIdList": ["PMC3092099", "21392406"]}, {"Citation": "Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen. 2010;51:304\u2013314.", "ArticleIdList": ["20120018"]}, {"Citation": "Carbonero F, Gaskins HR. Sulfate-Reducing Bacteria in the Human Gut Microbiome. Encyclopedia of Metagenomics. 2014:1\u20133."}, {"Citation": "Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe. 2013;14:207\u2013215.", "ArticleIdList": ["PMC3772512", "23954159"]}, {"Citation": "Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell host & microbe. 2013;14:195\u2013206.", "ArticleIdList": ["PMC3770529", "23954158"]}, {"Citation": "Everard A, Lazarevic V, Gaia N, Johansson M, Stahlman M, Backhed F, Delzenne NM, Schrenzel J, Francois P, Cani PD. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014;8:2116\u20132130.", "ArticleIdList": ["PMC4163056", "24694712"]}, {"Citation": "Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Current gastroenterology reports. 2010;12:319\u2013330.", "ArticleIdList": ["PMC2933006", "20703838"]}, {"Citation": "Menendez A, Brett Finlay B. Defensins in the immunology of bacterial infections. Curr Opin Immunol. 2007;19:385\u2013391.", "ArticleIdList": ["17702560"]}, {"Citation": "Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11:76\u201383.", "ArticleIdList": ["PMC2795796", "19855381"]}, {"Citation": "Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR) Clin Exp Immunol. 1995;101:428\u2013435.", "ArticleIdList": ["PMC1553229", "7664489"]}, {"Citation": "Ko CW, Cuthbert RJ, Orsi NM, Brooke DA, Perry SL, Markham AF, Coletta PL, Hull MA. Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice. The Journal of pathology. 2008;214:603\u2013609.", "ArticleIdList": ["18220315"]}, {"Citation": "Lahm H, Schnyder B, Wyniger J, Borbenyi Z, Yilmaz A, Car BD, Fischer JR, Givel JC, Ryffel B. Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int J Cancer. 1994;59:440\u2013447.", "ArticleIdList": ["7927955"]}, {"Citation": "Okada H, Kuwashima N. Gene therapy and biologic therapy with interleukin-4. Current gene therapy. 2002;2:437\u2013450.", "ArticleIdList": ["12477255"]}, {"Citation": "Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proceedings of the National Academy of Sciences of the United States of America; 1994; pp. 3652\u20133656.", "ArticleIdList": ["PMC43639", "8170963"]}, {"Citation": "Xu LL, Warren MK, Rose WL, Gong W, Wang JM. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. Journal of leukocyte biology. 1996;60:365\u2013371.", "ArticleIdList": ["8830793"]}, {"Citation": "Kikuchi H, Hanazawa S, Takeshita A, Nakada Y, Yamashita Y, Kitano S. Interleukin-4 acts as a potent stimulator for expression of monocyte chemoattractant JE/MCP-1 in mouse peritoneal macrophages. Biochemical and biophysical research communications. 1994;203:562\u2013569.", "ArticleIdList": ["8074704"]}, {"Citation": "McGhee JR, Fujihashi K. Inside the mucosal immune system. PLoS Biol. 2012;10:e1001397.", "ArticleIdList": ["PMC3457930", "23049482"]}, {"Citation": "Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun. 2011;25:397\u2013407.", "ArticleIdList": ["PMC3039072", "21040780"]}, {"Citation": "Wu PK, Tai CS, Choi CY, Tsim WK, Zhou H, Liu X, Jiang ZH, Hsiao WL. Chemical and DNA authentication of taste variants of Gynostemma pentaphyllum herbal tea. Food Chemistry. 2011;128:70\u201380.", "ArticleIdList": ["25214331"]}, {"Citation": "Wilson LA, Sharp PM. Enterobacterial repetitive intergenic consensus (ERIC) sequences in Escherichia coli: Evolution and implications for ERIC-PCR. Molecular biology and evolution. 2006;23:1156\u20131168.", "ArticleIdList": ["16533821"]}, {"Citation": "Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010;7:335\u2013336.", "ArticleIdList": ["PMC3156573", "20383131"]}, {"Citation": "Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome biology. 2011;12:R60.", "ArticleIdList": ["PMC3218848", "21702898"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "10", "Day": "20"}, {"Year": "2016", "Month": "4", "Day": "2"}, {"Year": "2016", "Month": "4", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27121311", "PMC5058752", "10.18632/oncotarget.8886", "8886"]}}], "PubmedBookArticle": []}